Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Cancer Prev Res (Phila). 2012 May 3;5(6):822–833. doi: 10.1158/1940-6207.CAPR-11-0559

Figure 5.

Figure 5

A, increased VASP phosphorylation and time-dependent decrease in nuclear β-catenin levels in HT-29 cells treated with SBA. B, decreased β-catenin–regulated protein, survivin after 10 μmol/L treatment with SBA. C, caspase-3 cleavage and PDE5 expression in HT-29 cells treated with 10 μmol/L SBA. D, Wnt/β-catenin signaling reporter activity in HCT 116 cells treated with SBA for 24 hours. E, suppression of β-catenin by 8-BrcGMP (100 μmol/L) in HCT 116 cells. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.